Trulicity 1,5 mg Solution for Injection
PDF Leaflet Revision Date: 08 September 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Adjunct to diet and exercise for glycaemic control in type 2 diabetes.
Dosage (summary)
1.5 mg once weekly, no adjustment for elderly.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding due to potential risks.
Key Drug Interactions
- May delay gastric emptying affecting oral medications
Contraindications
- Hypersensitivity to dulaglutide
- Personal/family history of MTC
- Pancreatitis
- Type 1 Diabetes Mellitus
- Diabetic ketoacidosis
- Severe gastrointestinal disease
Common side effects
- Nausea
- Vomiting
- Diarrhoea
- Hypoglycaemia
Counselling Points
- Administer once weekly
- Monitor for signs of thyroid tumours
- Stay hydrated to avoid dehydration
Serious warnings
- Risk of thyroid C-cell tumours
- Dehydration risk
- Acute pancreatitis risk
Important Disclaimer
The Trulicity 1,5 mg Solution for Injection professional information leaflet below is the property of Eli Lilly (SA) and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
